Genmab A/S(NASDAQ:GMAB) 
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye d...
Website: http://www.genmab.com
Founded: 1999
Full Time Employees: 712
CEO: Jan G. J. van de Winkel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 18.80
H 18.89
L 18.30
C 18.39
V 2,338,282
10EMA 18.39
20EMA 18.39
60EMA 18.39
120EMA 18.39
250EMA 18.39